Network Pharmacology and Molecular Docking Identify the Potential Mechanism and Therapeutic Role of Scutellaria baicalensis in Alzheimer's Disease

DOI: https://doi.org/10.2147/dddt.s450739

IF: 4.3188

2024-04-18

Drug Design Development and Therapy

Abstract:Yutao Peng, 1 Chanjuan Zhou 2 1 Department of Function, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, People's Republic of China; 2 Department of Clinical Psychology, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, People's Republic of China Correspondence: Chanjuan Zhou, Department of Clinical psychology, The First Affiliated Hospital, Hengyang Medical School, University of South China, 69 Chuan Shan Road, Hengyang, Hunan, 421001, People's Republic of China , Tel +86 13212694904 , Email Aim: Scutellaria baicalensis , a traditional Chinese medicinal herb renowned for its anti-inflammatory, antioxidant, and anti-tumor properties, has shown promise in alleviating cognitive impairment associated with Alzheimer's disease. Nonetheless, the exact neuroprotective mechanism of Scutellaria baicalensis against Alzheimer's disease remains unclear. In this study, network pharmacology was employed to explore the possible mechanisms by which Scutellaria baicalensis protects against Alzheimer's disease. Methods: The active compounds of Scutellaria baicalensis were retrieved from the TCMSP database, and their corresponding targets were identified. Alzheimer's disease-related targets were obtained through searches in the GeneCards and OMIM databases. Cytoscape 3.6.0 software was utilized to construct a regulatory network illustrating the "active ingredient-target" relationships. Subsequently, the target genes affected by Scutellaria baicalensis in the context of Alzheimer's disease were input into the String database to establish a PPI network. GO analysis and KEGG analysis were conducted using the DAVID database to predict the potential pathways associated with these key targets. Following this, the capacity of these active ingredients to bind to core targets was confirmed through molecular docking. In vitro experiments were then carried out for further validation. Results: A total of 36 active ingredients from Scutellaria baicalensis were screened out, which corresponded to 365 targets. Molecular docking results demonstrated the robust binding abilities of Baicalein, Wogonin, and 5,2'-Dihydroxy-6,7,8-trimethoxyflavone to key target proteins (SRC, PIK3R1, and STAT3). In vitro experiments showed that the active components of Scutellaria baicalensis can inhibit STAT3 expression by downregulating the PIK3R1/SRC pathway in Neuro 2A cells. Conclusion: In summary, these findings collectively suggest that Scutellaria baicalensis holds promise as a viable treatment option for Alzheimer's disease. Keywords: Scutellaria baicalensis , Alzheimer's disease, network pharmacology, molecular docking Alzheimer's disease is a prevalent neurodegenerative disorder, accounting for 50% to 75% of dementia cases, with no current cure available. 1,2 Patients with Alzheimer's disease exhibit clinical manifestations such as memory impairment, cognitive decline, behavioral disturbances, and impaired daily functioning. 3,4 There is an urgent demand for effective treatments for Alzheimer's disease. Presently, drugs targeting cholinergic and glutamatergic neurotransmission are the mainstay of Alzheimer's treatment, offering symptom relief but with contentious neuroprotective effects. 5,6 Consequently, the search for novel Alzheimer's treatments remains imperative. Traditional Chinese medicine, with a history spanning over 2500 years in the Chinese healthcare system, has revealed numerous bioactive compounds within Chinese herbs that have demonstrated efficacy in treating various ailments. Of notable significance, traditional Chinese medicine has emerged as a promising approach for addressing the treatment of Alzheimer's disease. 7–9 Scutellaria baicalensis , an herb belonging to the platycodon family, is commonly used in the treatment of bacterial pneumonia, colds, and insomnia. Recently, numerous chemical, pharmacological, and clinical investigations have demonstrated its neuroprotective, 10–12 anti-tumor, 13 antioxidant, 14,15 and anti-inflammatory 16 properties. Notably, it has been reported that Scutellaria baicalensis attenuates neuronal loss and improves memory and neuroplasticity disorders in rats with Alzheimer's disease. 17,18 However, the comprehensive mechanism of Scutellaria baicalensis intervention in Alzheimer's disease remains unclear, with limited research at the molecular level. Alzheimer's disease is influenced by alterations in multiple gene expressions; therefore, drugs targeting a single pathway may not -Abstract Truncated-

pharmacology & pharmacy,chemistry, medicinal